miR-20a-5p targets TGFBR-2. miR-20a-5p downregulation leads to TGFBR2-mediated TGF-β pathway activation, leading to inflammation in liver fibrosis (Fu et al., 2020; Zhou et al., 2015). Here, TGFB1 is linked to Hepatic fibrosis.